News | Cath Lab | June 20, 2019

New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium

Major cardiovascular conferences will collaborate on creating educational content for each other

New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium

June 20, 2019 – VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter Cardiovascular Therapeutics (TCT) and the VEITHsymposium. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. VEITHsymposium is the leading global conference covering all aspects of vascular medicine, vascular surgery and endovascular intervention.

As part of this alliance, the two organizations will closely collaborate on creating educational content for physicians, surgeons and other healthcare professionals. The VEITHsymposium leadership will be actively involved in developing the endovascular program for TCT 2019, taking place Sept. 25-29 in San Francisco. The VEITHsymposium group will also plan dedicated critical limb ischemia and aortic sessions at TCT 2019. Similarly, CRF will actively participate in the development of a two-day hands-on training pavilion and other interventional sessions at this year’s VEITHsymposium, which will take place Nov. 19-23 in New York City.

“We are pleased to be partnering with such an esteemed educational conference as the VEITHsymposium,” said Juan F. Granada, M.D., president and CEO of CRF. “Over the last 45 years, they have had a remarkable influence on medical education and innovation in the field, which has had a tremendous impact on patient care.”

Watch the VIDEO: Cath Lab of the Future Cardiovascular Technologies to Watch, an interview with Granada at TCT 2017.

“This alliance between two leading continuing medical educational meetings has as its goal the provision of the best, most up-to-date information possible to all those specializing in the care of non-cardiac vascular disease patients,” said Frank J. Veith, chairman of VEITHsymposium.  “This unique alliance will lead to better, more appropriate care for the increasing number of vascular disease patients around the world, while recognizing the reality that many specialties are involved in providing this care.”

“Vascular disease is a leading cause of death and disability,” said Sahil A. Parikh, M.D., director, endovascular services at the Center for Interventional Vascular Therapy at New York-Presbyterian/ Columbia University Irving Medical Center and director of the endovascular program of TCT. “It’s critically important for physicians and other healthcare professionals to be educated and trained on the latest endovascular treatments. This alliance will help improve the survival and quality of life for patients with vascular disease by emphasizing multidisciplinary care of vascular patients.”

"Limitless opportunities for improved care of vascular patients is the primary goal of this new and exciting alliance between two well established giants in the area of education,” said Enrico Ascher, M.D., co-chairman of VEITHsymposium. “Providing a balanced, progressive environment where all vascular care professionals can learn from each other is one other motivating factor that led to this arrangement. I’m certain that this new concept of working together for the benefit of our patients and for the advancement of science will succeed big time!”

“For decades, TCT has been the foremost conference for cardiovascular interventional therapy and the VEITHsymposium has been the leading meeting for non-cardiac vascular medicine and surgery,” said Kenneth Ouriel, M.D., MBA, co-chairman of VEITHsymposium. “The new alliance provides the opportunity to expand non-cardiac vascular educational offerings at TCT and interventional cardiology opportunities at the VEITHsymposium. The end result will be the most comprehensive cardiovascular conference in the world today.”

For more information: www.crf.org, www.veithsymposium.org


Related Content

News | Cath Lab

May 31, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, announced that the company has received ...

Home May 31, 2022
Home
News | Cath Lab

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

Home May 26, 2022
Home
News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
Subscribe Now